Investor Relations Captor Therapeutics ®
Shareholders
| Shareholder | Total number of shares | Total number of votes | Percentage of share capital | Percentage of total votes at the GSM | |
|---|---|---|---|---|---|
| 1. | Michał Walczak | 932 528 | 1 473 545 | 16,97% | 22,18% |
| 2. | Paweł Holstinghausen-Holsten | ||||
| directly | 363 186 | 723 261 | 6,61% | 10,89% | |
| indirectly via the Holstinghausen-Holsten Family Foundation | 236 112 | 236 1112 | 4,30% | 3,55% | |
| total | 599 298 | 959 373 | 10,91% | 14,44% | |
| 3. | Sylvain Cottens | 340 897 | 526 730 | 6,20% | 7,93% |
| 4. | TFI Allianz Polska S.A. | 343 483 | 343 483 | 6,25% | 5,17% |
| 6. | Others | 3 279 365 | 3 339 833 | 59,67% | 50,28% |
| Total | 5 495 571 | 6 642 964 | 100,00% | 100,00% |